Select Page

📈 INTRADAY WATCHLIST – April 14, 2026

by | Apr 14, 2026 | Communication Services / Electronic Gaming & Multimedia, Consumer Staples / Household & Personal Products, Healthcare / Biotechnology, Healthcare / Medical Instruments & Supplies, Intraday Watchlist, Technology / Information Technology Services, Technology / Software—Application, Utilities / Utilities—Renewable

Market Overview U.S. equities are surging in early trade as small-cap momentum dominates, led by biotech, tech, and industrial names with explosive volume and news catalysts. Traders are focused on high RVOL runners and fresh headlines, with risk appetite elevated and...

📈 PREMARKET WATCHLIST – April 9, 2026

by | Apr 8, 2026 | Communication Services / Electronic Gaming & Multimedia, Consumer Cyclical / Auto & Truck Dealerships, Financial Services / Asset Management, Healthcare / Health Information Services, Healthcare / Medical Devices, Industrials / Specialty Business Services, Premarket Watch List, Real Estate / REIT - Diversified, Technology / Software - Application, Technology / Software - Infrastructure

Market Overview After-hours trading on April 8, 2026 delivered massive continuation moves with DKI surging 96% on heavy volume and UCAR posting another 27% gain on 64M shares. Low-float runners, squeeze setups, and filing-driven momentum in gaming, AI, and specialty...

📈 PREMARKET WATCHLIST – April 7, 2026

by | Apr 6, 2026 | Communication Services / Electronic Gaming & Multimedia, Financial Services / Software - Infrastructure, Healthcare / Biotechnology, Healthcare / Diagnostics & Research, Healthcare / Drug Manufacturers - Specialty & Generic, Healthcare / Managed Health Care, Healthcare / Medical Instruments & Supplies, Premarket Watch List, Technology / Capital Markets, Technology / Computer Hardware, Technology / Software - Application

Market Overview Small-cap momentum is accelerating into Tuesday’s open after explosive after-hours action in low-float healthcare, biotech, AI, and regenerative medicine names. Multiple tickers delivered 20–75% gains on massive RVOL, driven by patent wins, FDA...